Request for Information on Effective, Large-Scale, Sustainable Approaches To Help People Quit Using Tobacco by Employing Evidence-Based Treatment Options, 50428-50429 [2017-23669]
Download as PDF
<![CDATA[
50428
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices
natural and human environment and
determined that the proposed action
would not result in significant adverse
impacts. Based on the results of the
Final EA, CDC has issued a FONSI
indicating the proposed action will not
have a significant impact on the
environment. The Build Alternative will
be undertaken in accordance with the
best management practices (BMPs),
minimization and mitigation measures
as presented in the Final EA and FONSI.
Dated: October 25, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2017–23668 Filed 10–30–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2017–0103]
Request for Information on Effective,
Large-Scale, Sustainable Approaches
To Help People Quit Using Tobacco by
Employing Evidence-Based Treatment
Options
Centers for Disease Control and
Prevention, Department of Health and
Human Services (HHS).
ACTION: Request for information.
AGENCY:
The Centers for Disease
Control and Prevention (CDC) within
the Department of Health and Human
Services (HHS) is requesting
information from the public to inform
future activities regarding how to
efficiently and cost effectively help
people quit using tobacco using
evidence-based treatment options.
DATES: Written comments must be
received on or by January 2, 2018.
ADDRESSES: Submit comments by any
one of the following methods:
• Internet: Electronic comments may
be sent via https://www.regulations.gov,
docket control number CDC–2017–0103.
Please follow the directions on the site
to submit comments; or
• Mail: Comments may also be sent
by mail to the attention of Pamela
Lemos, Office on Smoking and Health,
Centers for Disease Control and
Prevention, 4770 Buford Highway, Mail
Stop F–79, Atlanta, GA 30341.
All relevant comments will be posted
without change to https://
www.regulations.gov including any
personal information provided.
FOR FURTHER INFORMATION CONTACT:
Pamela Lemos, Office on Smoking and
asabaliauskas on DSKBBXCHB2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:37 Oct 30, 2017
Jkt 244001
Health, Centers for Disease Control and
Prevention, 4770 Buford Highway,
Atlanta, GA 30341; Telephone (770)
488–5709; Email: OSHFRN@cdc.gov.
SUPPLEMENTARY INFORMATION:
Scope of Problem
Cigarette smoking is the leading cause
of premature death and disease in the
United States, causing about 480,000
deaths each year and costing the
country over $300 billion annually in
health care spending and lost
productivity.1 2 Helping tobacco users
quit completely is the quickest approach
to reducing tobacco-related disease,
death, and costs.7 Quitting smoking has
immediate and long-term health
benefits.1 While quitting smoking at any
age is beneficial, smokers who quit by
the age of 35 to 44 years can prevent
most of the risk of dying from a
smoking-related disease.1 8
Most cigarette smokers say that they
want to quit, more than half try to quit
each year, and almost three in five
American adults who ever smoked have
quit.3 Several treatments are proven
effective in helping tobacco users quit,
including individual, group, and
telephone counseling and seven FDAapproved cessation medications.3 4
Receiving advice to quit and quitting
assistance from health care providers
also increases quit rates.4 5 The use of
both counseling and medication when
trying to quit is more effective than
using either method alone.4 5 However,
only one-third of smokers use
counseling and/or medication when
trying to quit, and only one in twenty
smokers use both.3 While adult cigarette
smoking rates have been declining
overall for several decades, certain
groups continue to smoke at high rates
and face special challenges in quitting,
including adults who live below the
poverty level and adults with behavioral
health conditions.6 Those with
behavioral health conditions include
adults with mental illness or substance
abuse disorders. The Substance Abuse
and Mental Health Services
Administration’s National Survey on
Drug Use and Health (NSDUH) defines
mental illness as any diagnosable
mental, behavioral, or emotional
disorder and defines substance use
disorder as dependence or abuse of
alcohol or illicit drugs.
Many resources are available to help
smokers connect with evidence-based
treatments. Telephone quitlines exist in
all states and other innovative and
emerging resources are available such as
web based platforms, texting, chat, and
mobile apps. Many smokers, however,
are unaware of these resources or have
misconceptions about them.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Approach
CDC is seeking information from the
public to inform future activities that
could efficiently and cost effectively
connect tobacco users with evidencebased treatment options to help them
quit. We plan to use the information
gathered to inform activities including,
but not limited to, state tobacco control
programming, national governmental
and nongovernmental organization
work, and other entities that work to
make broadly available and sustainable
connections between people who want
to quit using tobacco and evidencebased cessation assistance.
The goal of this effort is to ensure that
all tobacco users who want help quitting
are aware of and have ready access to
evidence-based treatment options
through channels that they are
comfortable using, including but not
limited to telephone quitlines. We will
carefully review and consider all
comments received to this request for
information.
CDC is specifically interested in
receiving information on the following
topics:
(1) How can CDC leverage emerging
technologies to deliver evidence-based
cessation interventions through new
and innovative platforms that have
broad reach, especially among younger
adults, those with low income, and
adults with chronic and/or behavioral
health conditions?
(2) What are some innovative
approaches to reduce the cost—in time,
staffing, and funding—of providing
effective cessation services to people
who want to quit using tobacco?
(3) How might standardization of
quitline services achieve greater
efficiency while also preserving state
quitlines’ ‘‘brands,’’ flexibility, and
capacity for innovation?
(4) What communication channels
and communication strategies should
CDC consider employing to ensure that
both tobacco users, including those
belonging to high-risk and
disadvantaged populations, and health
care providers are aware of and have
access to evidence-based cessation
resources?
(5) What role should CDC, state and
local health departments, not for profit
institutions, traditional healthcare
providers, and/or professional
healthcare partner organizations, play in
ensuring that high-risk populations
(such as smokers living below the
poverty level or those with behavioral
health conditions) have access to
tailored cessation services of
appropriate intensity to help them
successfully quit?
E:\FR\FM\31OCN1.SGM
31OCN1
Federal Register / Vol. 82, No. 209 / Tuesday, October 31, 2017 / Notices
50429
Dated: October 25, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2017–23669 Filed 10–30–17; 8:45 am]
[Docket No. FDA–2017–N–5897]
References
asabaliauskas on DSKBBXCHB2PROD with NOTICES
(6) How can CDC support state and
local health departments, traditional
healthcare providers, not for profit
health institutions, and professional
healthcare partner organizations to
ensure that evidence-based tobacco
cessation interventions are integrated
into primary and behavioral health care
settings on a consistent and sustainable
basis?
(7) How can the public health sector
most effectively maximize the impact of
public and private insurance coverage of
cessation treatments as part of efforts to
ensure that all tobacco users have
barrier-free access to these treatments?
Final Immediately Dangerous to Life or
Health (IDLH) Value Profiles
1. U.S. Department of Health and Human
Services. The Health Consequences of
Smoking—50 Years of Progress: A Report
of the Surgeon General. Atlanta: U.S.
Department of Health and Human
Services, Centers for Disease Control and
Prevention, National Center for Chronic
Disease Prevention and Health
Promotion, Office on Smoking and
Health, 2014.
2. Xu X, Bishop EE, Kennedy SM, Simpson
SA, Pechacek TF. Annual Healthcare
Spending Attributable to Cigarette
Smoking: An Update. American Journal
of Preventive Medicine 2014;48(3):326–
33.
3. Babb S, Malarcher A, Schauer G, Asman
K, Jamal A. Quitting Smoking Among
Adults—United States, 2000–2015.
MMWR Morb Mortal Wkly Rep
2017;65:1457–1464.
4. Siu AL; US Preventive Services Task
Force. Behavioral and pharmacotherapy
interventions for tobacco smoking
cessation in adults, including pregnant
women: U.S. Preventive Services Task
Force recommendation statement. Ann
Intern Med 2015;163:622–34.
´
5. Fiore MC, Jaen CR, Baker TB, et al.
Treating Tobacco Use and Dependence:
2008 Update—Clinical Practice
Guidelines. Rockville (MD): U.S.
Department of Health and Human
Services, Public Health Service, Agency
for Healthcare Research and Quality,
2008.
6. Jamal A, King BA, Neff LJ, Whitmill J,
Babb SD, Graffunder CM. Current
Cigarette Smoking Among Adults—
United States, 2005–2015. MMWR Morb
Mortal Wkly Rep 2016;65:1205–1211.
7. Institute of Medicine. Ending the Tobacco
Problem: A Blueprint for the Nation.
Washington: The National Academies
Press, 2007.
8. Jha P, Ramasundarahettige C, Landsman V,
Rostron B, Thun M, Anderson RN,
McAfee T, Peto R. 21st-century hazards
of smoking and benefits of cessation in
the United States. New England Journal
of Medicine 2013;368(4):341–50.
VerDate Sep<11>2014
17:37 Oct 30, 2017
Jkt 244001
Food and Drug Administration
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Packaging, Storage, and Disposal
Options To Enhance Opioid Safety—
Exploring the Path Forward; Public
Workshop; Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice of public workshop;
request for comments.
ACTION:
[CDC–2017–0048; Docket Number NIOSH–
156–C]
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
AGENCY:
ACTION:
Notice of availability.
NIOSH announces the
availability of the following four
Immediately Dangerous to Life or Health
(IDLH) Value Profile documents:
Acetonitrile [CAS No. 75–05–8],
Chloroacetonitrile [CAS No. 107–14–2],
Methacrylonitrile [CAS No. 126–98–7],
and Nitrogen dioxide [CAS No. 10102–
44–0].
SUMMARY:
The final IDLH Value Profile
documents were published on
September 29, 2017.
DATES:
These documents may be
obtained at the following link: https://
www.cdc.gov/niosh/idlh/default.html.
ADDRESSES:
R.
Todd Niemeier, MS, CIH, NIOSH,
Education and Information Division
(EID), Robert A. Taft Laboratories, 1090
Tusculum Ave., MS–C32, Cincinnati,
OH 45226, phone 513/533–8166 (not a
toll-free number), email: rbn4@cdc.gov.
FOR FURTHER INFORMATION CONTACT:
On May 5,
2017, NIOSH published a request for
public review in the Federal Register
[82 FR 21239] on IDLH Value profiles.
We did not receive public comments,
but did receive peer and stakeholder
comments. These comments received
were reviewed and addressed where
appropriate.
SUPPLEMENTARY INFORMATION:
Frank Hearl,
Chief of Staff, National Institute for
Occupational Safety and Health, Centers for
Disease Control and Prevention.
[FR Doc. 2017–23665 Filed 10–30–17; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
The Food and Drug
Administration (FDA, the Agency, or
we) is announcing the following public
workshop entitled ‘‘Packaging, Storage,
and Disposal Options To Enhance
Opioid Safety—Exploring the Path
Forward.’’ The purpose of this 2-day
public workshop is to host a scientific
discussion with experts and seek input
from interested stakeholders regarding
the role of packaging, storage, and
disposal options within the larger
landscape of activities aimed at
addressing abuse, misuse, or
inappropriate access of prescription
opioid drug products (opioids); guiding
principles and considerations for the
design of packaging, storage, and
disposal options for opioids; integrating
packaging, storage, and disposal options
into existing health care and pharmacy
systems, including both open and
closed health care systems (e.g., a closed
system such as the U.S. Department of
Veterans Affairs); data needs and how to
address challenges in assessing the
impact of packaging, storage, and
disposal options in both the premarket
and postmarket settings; and ways in
which FDA could encourage the
development and assessment of
packaging, storage, and disposal options
for opioids that have the potential to
enhance opioid safety.
DATES: The public workshop will be
held on December 11 and 12, 2017, from
8:30 a.m. to 5 p.m. Submit either
electronic or written comments on this
public workshop by February 12, 2018.
See the SUPPLEMENTARY INFORMATION
section for registration date and
information.
SUMMARY:
The public workshop will
be held at the Sheraton Silver Spring
Hotel, 8777 Georgia Ave., Silver Spring,
MD 20910. The hotel’s phone number is
301–589–0800.
You may submit comments as
follows. Please note that late, untimely
filed comments will not be considered.
Electronic comments must be submitted
on or before February 12, 2018. The
ADDRESSES:
E:\FR\FM\31OCN1.SGM
31OCN1
]]>Agencies
[Federal Register Volume 82, Number 209 (Tuesday, October 31, 2017)]
[Notices]
[Pages 50428-50429]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-23669]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2017-0103]
Request for Information on Effective, Large-Scale, Sustainable
Approaches To Help People Quit Using Tobacco by Employing Evidence-
Based Treatment Options
AGENCY: Centers for Disease Control and Prevention, Department of
Health and Human Services (HHS).
ACTION: Request for information.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) within
the Department of Health and Human Services (HHS) is requesting
information from the public to inform future activities regarding how
to efficiently and cost effectively help people quit using tobacco
using evidence-based treatment options.
DATES: Written comments must be received on or by January 2, 2018.
ADDRESSES: Submit comments by any one of the following methods:
Internet: Electronic comments may be sent via https://www.regulations.gov, docket control number CDC-2017-0103. Please follow
the directions on the site to submit comments; or
Mail: Comments may also be sent by mail to the attention
of Pamela Lemos, Office on Smoking and Health, Centers for Disease
Control and Prevention, 4770 Buford Highway, Mail Stop F-79, Atlanta,
GA 30341.
All relevant comments will be posted without change to https://www.regulations.gov including any personal information provided.
FOR FURTHER INFORMATION CONTACT: Pamela Lemos, Office on Smoking and
Health, Centers for Disease Control and Prevention, 4770 Buford
Highway, Atlanta, GA 30341; Telephone (770) 488-5709; Email:
[email protected].
SUPPLEMENTARY INFORMATION:
Scope of Problem
Cigarette smoking is the leading cause of premature death and
disease in the United States, causing about 480,000 deaths each year
and costing the country over $300 billion annually in health care
spending and lost productivity.1 2 Helping tobacco users
quit completely is the quickest approach to reducing tobacco-related
disease, death, and costs.\7\ Quitting smoking has immediate and long-
term health benefits.\1\ While quitting smoking at any age is
beneficial, smokers who quit by the age of 35 to 44 years can prevent
most of the risk of dying from a smoking-related disease.1 8
Most cigarette smokers say that they want to quit, more than half
try to quit each year, and almost three in five American adults who
ever smoked have quit.\3\ Several treatments are proven effective in
helping tobacco users quit, including individual, group, and telephone
counseling and seven FDA-approved cessation medications.3 4
Receiving advice to quit and quitting assistance from health care
providers also increases quit rates.4 5 The use of both
counseling and medication when trying to quit is more effective than
using either method alone.4 5 However, only one-third of
smokers use counseling and/or medication when trying to quit, and only
one in twenty smokers use both.\3\ While adult cigarette smoking rates
have been declining overall for several decades, certain groups
continue to smoke at high rates and face special challenges in
quitting, including adults who live below the poverty level and adults
with behavioral health conditions.\6\ Those with behavioral health
conditions include adults with mental illness or substance abuse
disorders. The Substance Abuse and Mental Health Services
Administration's National Survey on Drug Use and Health (NSDUH) defines
mental illness as any diagnosable mental, behavioral, or emotional
disorder and defines substance use disorder as dependence or abuse of
alcohol or illicit drugs.
Many resources are available to help smokers connect with evidence-
based treatments. Telephone quitlines exist in all states and other
innovative and emerging resources are available such as web based
platforms, texting, chat, and mobile apps. Many smokers, however, are
unaware of these resources or have misconceptions about them.
Approach
CDC is seeking information from the public to inform future
activities that could efficiently and cost effectively connect tobacco
users with evidence-based treatment options to help them quit. We plan
to use the information gathered to inform activities including, but not
limited to, state tobacco control programming, national governmental
and nongovernmental organization work, and other entities that work to
make broadly available and sustainable connections between people who
want to quit using tobacco and evidence-based cessation assistance.
The goal of this effort is to ensure that all tobacco users who
want help quitting are aware of and have ready access to evidence-based
treatment options through channels that they are comfortable using,
including but not limited to telephone quitlines. We will carefully
review and consider all comments received to this request for
information.
CDC is specifically interested in receiving information on the
following topics:
(1) How can CDC leverage emerging technologies to deliver evidence-
based cessation interventions through new and innovative platforms that
have broad reach, especially among younger adults, those with low
income, and adults with chronic and/or behavioral health conditions?
(2) What are some innovative approaches to reduce the cost--in
time, staffing, and funding--of providing effective cessation services
to people who want to quit using tobacco?
(3) How might standardization of quitline services achieve greater
efficiency while also preserving state quitlines' ``brands,''
flexibility, and capacity for innovation?
(4) What communication channels and communication strategies should
CDC consider employing to ensure that both tobacco users, including
those belonging to high-risk and disadvantaged populations, and health
care providers are aware of and have access to evidence-based cessation
resources?
(5) What role should CDC, state and local health departments, not
for profit institutions, traditional healthcare providers, and/or
professional healthcare partner organizations, play in ensuring that
high-risk populations (such as smokers living below the poverty level
or those with behavioral health conditions) have access to tailored
cessation services of appropriate intensity to help them successfully
quit?
[[Page 50429]]
(6) How can CDC support state and local health departments,
traditional healthcare providers, not for profit health institutions,
and professional healthcare partner organizations to ensure that
evidence-based tobacco cessation interventions are integrated into
primary and behavioral health care settings on a consistent and
sustainable basis?
(7) How can the public health sector most effectively maximize the
impact of public and private insurance coverage of cessation treatments
as part of efforts to ensure that all tobacco users have barrier-free
access to these treatments?
References
1. U.S. Department of Health and Human Services. The Health
Consequences of Smoking--50 Years of Progress: A Report of the
Surgeon General. Atlanta: U.S. Department of Health and Human
Services, Centers for Disease Control and Prevention, National
Center for Chronic Disease Prevention and Health Promotion, Office
on Smoking and Health, 2014.
2. Xu X, Bishop EE, Kennedy SM, Simpson SA, Pechacek TF. Annual
Healthcare Spending Attributable to Cigarette Smoking: An Update.
American Journal of Preventive Medicine 2014;48(3):326-33.
3. Babb S, Malarcher A, Schauer G, Asman K, Jamal A. Quitting
Smoking Among Adults--United States, 2000-2015. MMWR Morb Mortal
Wkly Rep 2017;65:1457-1464.
4. Siu AL; US Preventive Services Task Force. Behavioral and
pharmacotherapy interventions for tobacco smoking cessation in
adults, including pregnant women: U.S. Preventive Services Task
Force recommendation statement. Ann Intern Med 2015;163:622-34.
5. Fiore MC, Ja[eacute]n CR, Baker TB, et al. Treating Tobacco Use
and Dependence: 2008 Update--Clinical Practice Guidelines. Rockville
(MD): U.S. Department of Health and Human Services, Public Health
Service, Agency for Healthcare Research and Quality, 2008.
6. Jamal A, King BA, Neff LJ, Whitmill J, Babb SD, Graffunder CM.
Current Cigarette Smoking Among Adults--United States, 2005-2015.
MMWR Morb Mortal Wkly Rep 2016;65:1205-1211.
7. Institute of Medicine. Ending the Tobacco Problem: A Blueprint
for the Nation. Washington: The National Academies Press, 2007.
8. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M,
Anderson RN, McAfee T, Peto R. 21st-century hazards of smoking and
benefits of cessation in the United States. New England Journal of
Medicine 2013;368(4):341-50.
Dated: October 25, 2017.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2017-23669 Filed 10-30-17; 8:45 am]
BILLING CODE 4163-18-P
